BAT Cow's Milk for the Replacement of the Food Challenge Test

NCT05064917 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2022-05-03

No results posted yet for this study

Summary

The prevalence of children suspected of a cow's milk allergy is 17% in the Netherlands. Cow's milk diagnosis is based on a food challenge test However, this food challenge test is expensive, time consuming, risky, with waiting lists of several months. This waiting time results in unnecessarily long-term use of expensive hypoallergenic milk formula Therefore, there is a great need to introduce a better and faster diagnostic test for cow's milk allergy diagnosis in standard care. The in vitro Basophil Activation Test (BAT) is cheap, quick (result \< 1 day, no waiting list), safe for the child and is a reliable alternative for the food challenge test to diagnose an IgE-mediated allergy. A diagnostic work-up with the BAT is expected to achieve a relevant reduction in the number of expensive and risky food challenges and the prescription of hypoallergenic formula. The reduction in diagnostic delay will increase quality of life.

Objective: Determination of the (cost)effectiveness of the replacement of the expensive, risky and time-consuming food challenge test by the Basophil Activation Test (BAT) for the diagnosis of an IgE-mediated cow's milk allergy in children.

Conditions

  • Cow Milk Allergy

Interventions

DIAGNOSTIC_TEST

Blood draw

The burden for child/parents in this study is low as it is limited to a single blood draw, which is already necessary for usual diagnostic care in about 70% of the children

Sponsors & Collaborators

  • Alrijne Hospital

    collaborator OTHER
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER
  • Bernhoven Hospital

    collaborator OTHER
  • Catharina Ziekenhuis Eindhoven

    collaborator OTHER
  • Elkerliek Hospital

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • Elisabeth-TweeSteden Ziekenhuis

    collaborator OTHER
  • Maasstadziekenhuis

    collaborator UNKNOWN
  • Meander Medisch Centrum

    collaborator OTHER
  • OLVG

    collaborator NETWORK
  • Spaarne Gasthuis

    collaborator OTHER
  • Franciscus Gasthuis

    collaborator OTHER
  • University Medical Center Groningen

    collaborator OTHER
  • UMC Utrecht

    collaborator OTHER
  • Viecurie Medisch Centrum voor Noord LImburg

    collaborator UNKNOWN
  • Zuyderland Medisch Centrum

    collaborator OTHER
  • Rijnstate Hospital

    lead OTHER

Eligibility

Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2025-12-01
Completion
2025-12-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05064917 on ClinicalTrials.gov